A Pharmacokinetic/Pharmacodynamic Drug–Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs-Reference-Cited by-同舟云学术

A Pharmacokinetic/Pharmacodynamic Drug–Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs

Published:2015-07-09 Issue:02 Volume:66 Page:74-81
ISSN:2194-9379
Container-title:Drug Research
language:en
Short-container-title:Drug Res (Stuttg)

Author:

Kasahara N.¹,Fukase H.²,Ohba Y.¹,Saito T.¹,Miyata K.¹,Iida S.¹,Takano Y.¹,Ikeda S.¹,Harigai M.³,Terao K.¹

Affiliation:

1. Clinical Research Planning Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan

2. CPC Clinical Trial Hospital, Medipolis Medical Research Institute, Kagoshima, Japan

3. Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan

Publisher

Georg Thieme Verlag KG

Subject

Drug Discovery,General Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1549967.pdf

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects;Translational and Clinical Pharmacology;2023

2. No apparent pharmacokinetic interactions were found between henagliflozin: A novel sodium‐glucose co‐transporter 2 inhibitor and glimepiride in healthy Chinese male subjects;Journal of Clinical Pharmacy and Therapeutics;2022-03-31

3. The effects of 12-month administration of tofogliflozin on electrolytes and dehydration in mainly elderly Japanese patients with type 2 diabetes mellitus;Journal of International Medical Research;2018-10-25

4. Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Tofogliflozin (A SELECTIVE SGLT2 Inhibitor) in Patients with Type 2 Diabetes Mellitus;Drug Research;2018-08-13

5. Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects;Drug Research;2017-04-20